R

C

RICHARD , Corentin

Last name: RICHARD

First name: Corentin

June 8, 2017 (v1)

Journal article

Metadata-only

Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer

Kaderbhai, Courèche-Guillaume Richard, Corentin Aarnink, Anne

Nivolumab, an anti PD-1 checkpoint inhibitor has demonstrated efficacy in metastatic non-small-cell lung cancer (NSCLC) patients after failure to standard chemotherapy. Standard chemotherapy agents could promote antitumor immune response. We thus examined whether the response to first line chemotherapy could impact on nivolumab benefit. One...

Uploaded on: February 28, 2023